This article reviews the relationship between postmenopausal hormone therapy and breast cancer risk. It finds that estrogen alone may slightly reduce breast cancer risk, while combined estrogen-progestin therapy significantly increases it. Notably, current estrogen-progestin use is linked to a higher risk of lobular cancer than ductal cancer, although the risk
